Ampio Pharm Stock Performance
| AMPE Stock | USD 0.01 0.25 96.15% |
Ampio Pharm holds a performance score of 26 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 95.0, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Ampio Pharm will likely underperform. Use Ampio Pharm sortino ratio and the relationship between the potential upside and day typical price , to analyze future returns on Ampio Pharm.
Risk-Adjusted Performance
Strong
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Ampio Pharm are ranked lower than 26 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Ampio Pharm exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 12.7 M | |
| Free Cash Flow | -8.6 M |
Ampio |
Ampio Pharm Relative Risk vs. Return Landscape
If you would invest 0.52 in Ampio Pharm on November 5, 2025 and sell it today you would earn a total of 0.48 from holding Ampio Pharm or generate 92.31% return on investment over 90 days. Ampio Pharm is currently generating 106.0491% in daily expected returns and assumes 322.0128% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Ampio, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Ampio Pharm Target Price Odds to finish over Current Price
The tendency of Ampio Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.01 | 90 days | 0.01 | about 65.89 |
Based on a normal probability distribution, the odds of Ampio Pharm to move above the current price in 90 days from now is about 65.89 (This Ampio Pharm probability density function shows the probability of Ampio Pink Sheet to fall within a particular range of prices over 90 days) .
Ampio Pharm Price Density |
| Price |
Predictive Modules for Ampio Pharm
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ampio Pharm. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Ampio Pharm Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Ampio Pharm is not an exception. The market had few large corrections towards the Ampio Pharm's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ampio Pharm, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ampio Pharm within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 561.19 | |
β | Beta against Dow Jones | 95.00 | |
σ | Overall volatility | 0.09 | |
Ir | Information ratio | 0.33 |
Ampio Pharm Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ampio Pharm for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ampio Pharm can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Ampio Pharm is not yet fully synchronised with the market data | |
| Ampio Pharm is way too risky over 90 days horizon | |
| Ampio Pharm has some characteristics of a very speculative penny stock | |
| Ampio Pharm appears to be risky and price may revert if volatility continues | |
| Ampio Pharm has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (8.63 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Ampio Pharm currently holds about 23.25 M in cash with (8.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.1, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from news.google.com: 270,284 traded Tengion volume spike 28 Jan 2026 liquidity is key - Meyka |
Ampio Pharm Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ampio Pink Sheet often depends not only on the future outlook of the current and potential Ampio Pharm's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ampio Pharm's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 810.1 K | |
| Cash And Short Term Investments | 4.1 M |
Ampio Pharm Fundamentals Growth
Ampio Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Ampio Pharm, and Ampio Pharm fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Ampio Pink Sheet performance.
| Return On Equity | -1.14 | |||
| Return On Asset | -0.62 | |||
| Current Valuation | (3.33 M) | |||
| Shares Outstanding | 1.14 M | |||
| Price To Earning | 28.57 X | |||
| Price To Book | 0.21 X | |||
| EBITDA | (8.63 M) | |||
| Cash And Equivalents | 23.25 M | |||
| Cash Per Share | 0.10 X | |||
| Total Debt | 274 K | |||
| Debt To Equity | 0.04 % | |||
| Book Value Per Share | 4.03 X | |||
| Cash Flow From Operations | (8.56 M) | |||
| Earnings Per Share | (10.66) X | |||
| Total Asset | 5.74 M | |||
| Retained Earnings | (242.53 M) | |||
| Current Asset | 29.23 M | |||
| Current Liabilities | 5.52 M | |||
About Ampio Pharm Performance
By analyzing Ampio Pharm's fundamental ratios, stakeholders can gain valuable insights into Ampio Pharm's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Ampio Pharm has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Ampio Pharm has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requiring oxygen supplementation AP-019, an Inhaled Ampion treatment, which is in Phase II clinical trial for the treatment of Adults with Respiratory Distress Due to COVID-19 and AP-018 that is in Phase I clinical trial to treat patients with prolonged respiratory symptoms due to COVID-19. Ampio Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 18 people.Things to note about Ampio Pharm performance evaluation
Checking the ongoing alerts about Ampio Pharm for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Ampio Pharm help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Ampio Pharm is not yet fully synchronised with the market data | |
| Ampio Pharm is way too risky over 90 days horizon | |
| Ampio Pharm has some characteristics of a very speculative penny stock | |
| Ampio Pharm appears to be risky and price may revert if volatility continues | |
| Ampio Pharm has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (8.63 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Ampio Pharm currently holds about 23.25 M in cash with (8.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.1, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from news.google.com: 270,284 traded Tengion volume spike 28 Jan 2026 liquidity is key - Meyka |
- Analyzing Ampio Pharm's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Ampio Pharm's stock is overvalued or undervalued compared to its peers.
- Examining Ampio Pharm's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Ampio Pharm's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Ampio Pharm's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Ampio Pharm's pink sheet. These opinions can provide insight into Ampio Pharm's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Ampio Pink Sheet analysis
When running Ampio Pharm's price analysis, check to measure Ampio Pharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ampio Pharm is operating at the current time. Most of Ampio Pharm's value examination focuses on studying past and present price action to predict the probability of Ampio Pharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ampio Pharm's price. Additionally, you may evaluate how the addition of Ampio Pharm to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |